ADAPTIMMUNE THERAPEUTICS PLC: cash_and_restricted_cash
| Value | {"amount": 82907000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | current |
| Entity | ADAPTIMMUNE THERAPEUTICS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:47.581907+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/63182ff1-d241-4e22-8aad-da706f5b1058
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-012867 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:47.581907+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621227/cash-and-restricted-cash/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/63182ff1-d241-4e22-8aad-da706f5b1058
History
- no predecessors — first report